Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study.
ESMO Open
; 7(3): 100446, 2022 06.
Article
in En
| MEDLINE
| ID: mdl-35427834
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Mesothelioma, Malignant
/
Lung Neoplasms
/
Mesothelioma
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
ESMO Open
Year:
2022
Type:
Article